FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

SUNPHARMA Share Price Discussion

Sun Pharmaceutical Industries Ltd.
NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Sector: Pharmaceuticals and health care

SUNPHARMA Rating

3.8/5 (25 Ratings)
SUNPHARMA Share Price *
376.7 +33.15 (9.65%)
* (quote may be delayed)
Find answers to all your questions on live SUNPHARMA message board: Is SUNPHARMA buy or sell? Should I buy SUNPHARMA shares? Why are SUNPHARMA shares falling? Should I invest in SUNPHARMA stock?

You can also check SUNPHARMA share price target recommended by brokerages.

SUNPHARMA Discussion Forum


SUNPHARMA - 701094
TODAY'S #BEST #JACKPOT🔥
#SUNPHARMA 🚀 #Futures
Like
reply
Reply
@walltimes • Reputation: 8,318
Wall Times in SUNPHARMA
SUNPHARMA APR20 FUT
New trade: Buy SUNPHARMA APR20 FUT, CMP@347.3, ...

384 high
Like
reply
Reply
@TTA • Reputation: 43,172

*SUN PHARMA RS 19.38 CRS NSE BLOCK TRADE; FOR~ 518970 SHARES, AT RS 373.40*
Like
reply
Reply
#ENRICHANSRAJPANDEY in SUNPHARMA
SUNPHARMA APR20 380 CE
New trade: Buy SUNPHARMA APR20 380 CE, CMP@16.1...

SUNPHARMA 💉💉💉FINAL TARGET DONE BOOK HUGE PROFIT AGAIN ♨️♨️♨️♨️
Like
reply
Reply
#ENRICHANSRAJPANDEY in SUNPHARMA
SUNPHARMA APR20 380 CE
New trade: Buy SUNPHARMA APR20 380 CE, CMP@16.1...

Sunpharma new high 21🚀🚀🚀🚀🚀
Like
reply
Reply
#ENRICHANSRAJPANDEY in SUNPHARMA
SUNPHARMA APR20 380 CE
New trade: Buy SUNPHARMA APR20 380 CE, CMP@16.1...

SUNPHARMA 380 CE. MADE A HIGH 19+++ ♨️♨️♨️
Like
reply
Reply
@mohan-B1lZEEB1E • Reputation: -45,188
SUNPHARMA APR20 300 PE

Type
Buy
Instrument
SUNPHARMA APR20 300 PE
Entry Price
₹4.9
Price@Trade
₹5.25
Target Price
₹11
Stop Price
₹0
Valid Till
Apr 30, 2020 3:20 AM
Margin
₹6,125 approx for 1250 Qty
Status
Active
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Today 5:37 AM

Update
Trade Entered
Entry Price
₹4.9
@sifm • Reputation: 11,185
SUNPHARMA APR20 FUT

Type
Buy
Instrument
SUNPHARMA APR20 FUT
Entry Price
₹370
Price@Trade
₹368.55
Target Price
₹382
Stop Price
₹365
Valid Till
Apr 3, 2020 3:20 AM
Margin
₹120,673.26 approx for 1250 Qty
Status
Target Achieved
Exit Price
₹382
Net P&L
12.43% Profit
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Today 4:57 AM

Update
Trade Entered
Entry Price
₹370
TrackerBot @trackerbot
Today 5:46 AM

Update
Target Achieved
Exit Price
₹382
SUNPHARMA APR20 380 CE

Type
Buy
Instrument
SUNPHARMA APR20 380 CE
Entry Price
₹16
Price@Trade
₹16.1
Target Price
₹23
Stop Price
₹13
Valid Till
Apr 3, 2020 3:20 AM
Margin
₹20,000 approx for 1250 Qty
Status
Target Achieved
Exit Price
₹23
Net P&L
43.75% Profit
1
reply
Reply (3)
Latest replies
TrackerBot @trackerbot
Today 4:50 AM

Update
Trade Entered
Entry Price
₹16
TrackerBot @trackerbot
Today 5:44 AM

Update
Target Achieved
Exit Price
₹23
Sanjeev @sanjeev6261
Today 12:03 PM

SUNPHARMA - 701047
Thakyou sir..... today again gatting good profit thank for support
@MONEYMAKESMONEY • Reputation: -2,631
SUNPHARMA

Type
Buy
Instrument
SUNPHARMA
Entry Price
₹351
Price@Trade
₹351
Target Price
₹390
Stop Price
₹335
Valid Till
Apr 30, 2020 3:20 AM
Margin
₹351 approx for 1 Qty
Status
Active
Like
reply
Reply
@bumblebee • Reputation: 4,359
SUNPHARMA

Type
Buy
Instrument
SUNPHARMA
Entry Price
₹350.5
Price@Trade
₹350.5
Target Price
₹365
Stop Price
₹338
Valid Till
Apr 3, 2020 3:20 AM
Margin
₹350.5 approx for 1 Qty
Status
Exited
Exit Price
₹360.5
Net P&L
2.85% Profit
Like
reply
Reply (1)
Latest replies
Bumblebee OPTION @bumblebee
Today 4:34 AM

Update
Exited
Exit Price
₹360.5
Net P&L
2.85% Profit
@walltimes • Reputation: 8,318
SUNPHARMA APR20 FUT

Type
Buy
Instrument
SUNPHARMA APR20 FUT
Entry Price
₹348
Price@Trade
₹347.3
Target Price
₹360
Stop Price
₹341
Valid Till
Apr 3, 2020 3:20 AM
Margin
₹118,857.15 approx for 1250 Qty
Status
Exited
Exit Price
₹350
Net P&L
2.1% Profit
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Today 2:52 AM

Update
Trade Entered
Entry Price
₹348
Wall Times  @walltimes
Today 2:59 AM

Update
Exited
Exit Price
₹350
Net P&L
2.1% Profit

"RISKY JACKPOT"
SUNPHARMA BUY @ 347 "CMP"
SL 346.50
TARGET "OPEN"
Like
reply
Reply (1)
Latest replies

NEW HIGH 350++ 🚀
(-600/- RISK PER LOT)😍
RISK 1: 7.70 TIMES PROFIT❤️
4,600/- PROFIT TILL NOW 👍
@santosh-Hyh2gPyPS • Reputation: 1,791
SUNPHARMA

Type
Buy
Instrument
SUNPHARMA
Entry Price
₹352
Price@Trade
₹354.2
Target Price
₹362
Stop Price
₹342
Valid Till
Apr 1, 2020 3:20 AM
Margin
₹352 approx for 1 Qty
Status
Stoploss Hit
Exit Price
₹342
Net P&L
-2.84% Loss
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Apr 1 4:09 AM

Update
Trade Entered
Entry Price
₹352
TrackerBot @trackerbot
Apr 1 4:37 AM

Update
Stoploss Hit
Exit Price
₹342
@ashishjshah • Reputation: -723
ASHISH SHAH in SUNPHARMA
444.50

355
Like
reply
Reply

INTRADAY & POSITIONAL
BUY SUNPHARMA
ABOVE 356
STOP LOSS 345
TARGETS 365 375 385 ++
Like
reply
Reply
@anirudhreddy • Reputation: -154
SUNPHARMA APR20 FUT

Type
Buy
Instrument
SUNPHARMA APR20 FUT
Entry Price
₹351.45
Price@Trade
₹351.45
Target Price
₹365
Stop Price
₹348
Valid Till
Apr 1, 2020 3:20 AM
Margin
₹123,259.39 approx for 1250 Qty
Status
Stoploss Hit
Exit Price
₹348
Net P&L
-3.5% Loss
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Apr 1 2:46 AM

Update
Stoploss Hit
Exit Price
₹348
@100billionclub • Reputation: 2,152
Billion Club in SUNPHARMA
BUY SUNPHARMA ABV 341

*ONCE EXIT LONG IN SUNPHARMA AT 347. BOOK PROFIT RS. 7,500*
Like
reply
Reply
@marketbull • Reputation: -32,320
SUNPHARMA APR20 FUT

Type
Buy
Instrument
SUNPHARMA APR20 FUT
Entry Price
₹348
Price@Trade
₹348
Target Price
₹400
Stop Price
₹325
Valid Till
Mar 31, 2020 3:20 AM
Margin
₹117,145.43 approx for 1250 Qty
Status
Exited
Exit Price
₹350.6
Net P&L
2.77% Profit
Like
reply
Reply (1)
Latest replies
BULL KING @marketbull
Mar 31 7:26 AM

Update
Exited
Exit Price
₹350.6
Net P&L
2.77% Profit
@marketbull • Reputation: -32,320
SUNPHARMA APR20 FUT

Type
Buy
Instrument
SUNPHARMA APR20 FUT
Entry Price
₹348
Price@Trade
₹348
Target Price
₹400
Stop Price
₹325
Valid Till
Mar 31, 2020 3:20 AM
Margin
₹117,163.1 approx for 1250 Qty
Status
Exited
Exit Price
₹350.75
Net P&L
2.93% Profit
Like
reply
Reply (1)
Latest replies
BULL KING @marketbull
Mar 31 7:26 AM

Update
Exited
Exit Price
₹350.75
Net P&L
2.93% Profit
@DVSTOCKS • Reputation: 220

Sun pharma buy abv 350
Like
reply
Reply (1)
Latest replies
D V VORA @DVSTOCKS
Mar 31 9:46 AM

355
@100billionclub • Reputation: 2,152

BUY SUNPHARMA ABV 341
Like
reply
Reply (1)
Latest replies
Billion Club @100billionclub
Mar 31 6:55 AM

*ONCE EXIT LONG IN SUNPHARMA AT 347. BOOK PROFIT RS. 7,500*
@ashishjshah • Reputation: -723
ASHISH SHAH in SUNPHARMA
Buy Sun Pharma 330 sl 325 tgt open

444.50
Like
reply
Reply
SUNPHARMA

Type
Sell
Instrument
SUNPHARMA
Entry Price
₹339.4
Price@Trade
₹339.4
Target Price
₹329
Stop Price
₹345
Valid Till
Mar 31, 2020 3:20 AM
Margin
₹339.4 approx for 1 Qty
Status
Stoploss Hit
Exit Price
₹345
Net P&L
-1.65% Loss
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Mar 31 5:10 AM

Update
Stoploss Hit
Exit Price
₹345
@tradingfab • Reputation: 895

31-03-20
SUNPHARMA APR PE 330 (Intraday)
only Above @ 25.70
Like
reply
Reply (4)
Latest replies
ska @ska-HJp6fP4e8
Mar 31 3:24 AM

buy or sell
Sameer  @tradingfab
Mar 31 3:27 AM

High 25.90 🔥🔥🚀
Sameer  @tradingfab
Mar 31 3:28 AM

High 26.35 🔥🔥💥🚀
Sameer  @tradingfab
Mar 31 3:33 AM

High 26.70 🔥🔥🚀🚀
@ashishjshah • Reputation: -723

Buy Sun Pharma 330 sl 325 tgt open
Like
reply
Reply
@niftystudy • Reputation: 132,481
SUNPHARMA

Type
Buy
Instrument
SUNPHARMA
Entry Price
₹337.35
Price@Trade
₹337.4
Target Price
₹600
Stop Price
₹250
Valid Till
Mar 30, 2021 3:20 AM
Margin
₹337.35 approx for 1 Qty
Status
Active
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Mar 30 7:32 AM

Update
Trade Entered
Entry Price
₹337.35
@balasubramaniam • Reputation: -109,990
SUNPHARMA APR20 FUT

Type
Buy
Instrument
SUNPHARMA APR20 FUT
Entry Price
₹337.3
Price@Trade
₹337.3
Target Price
₹500
Stop Price
₹250
Valid Till
Apr 30, 2020 3:20 AM
Margin
₹114,608.89 approx for 1250 Qty
Status
Active
Like
reply
Reply
@newsbot • Reputation: 2,570
Sun Pharma share falls 7% on USFDA red flag, but pares all losses
CLSA reiterated buy rating on the stock, though it slashed price target Rs 520 (from Rs 540 per share) on expected lower earnings.
Moneycontrol
Like
reply
Reply
@tradingfab • Reputation: 895

30-03-20 Intraday BUY SUNPHARMA in cash
only Above @ 331
Like
reply
Reply (11)
Latest replies
Sameer  @tradingfab
Mar 30 3:57 AM

High 336.80 🔥🔥🚀🚀
Sameer  @tradingfab
Mar 30 4:02 AM

Hit 339.70 🔥🔥🚀🚀
Sameer  @tradingfab
Mar 30 4:11 AM

hit 342 🔥🚀🚀
ska @ska-HJp6fP4e8
Mar 30 4:14 AM

selling now
ska @ska-HJp6fP4e8
Mar 30 4:14 AM

339

💠💠
YOUR FREE EQUITY CASH CALL FOR THIS FORUM TODAY:
SELL SUN PHARMA (HALAOL NEWS) AT THE VERY BEGINING
STRICT STOP LOSS - 345
1ST TARGET - 333
2ND TARGET - 325
3RD TARGET - 318
## GO WITH SAFER QUANTITY ##
Disclaimer: All my Views/Suggestions/Calls are for Education Purpose On...
Read more...
Like
reply
Reply
@newsbot • Reputation: 2,570
Stocks in the news: Stocks in the news: SBI, IDBI Bank, Tata Power, Graphite, Lupin, Godawari Power, Sun Pharma
Sun Pharma | SBI | Abott India | HeidelbergCement India | Sobha and aviation stocks are in the news today.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,570
Coronavirus pandemic | Sun Pharma commits Rs 25 cr worth of drugs, sanitisers to fight COVID-19
"The company is committed to working closely with the governments and relevant stakeholders to ensure that there is uninterrupted supply of medicines," Sun Pharma said in a statement.
Moneycontrol
Like
reply
Reply
@tradingfab • Reputation: 895

27-03-20
SUNPHARMA APR PE 340 (Intraday)
only Above @ 29.60
Like
reply
Reply (3)
Latest replies
Sameer  @tradingfab
Mar 27 4:16 AM

High 30 🔥🔥🔥
Sameer  @tradingfab
Mar 27 4:18 AM

High 30.35 🔥🔥🔥🚀
Sameer  @tradingfab
Mar 27 6:41 AM

31.55 🔥🔥🔥
@sifm • Reputation: 11,185
SUNPHARMA MAR20 FUT

Type
Sell
Instrument
SUNPHARMA MAR20 FUT
Entry Price
₹340
Price@Trade
₹337.65
Target Price
₹330
Stop Price
₹350
Valid Till
Mar 26, 2020 3:20 AM
Margin
₹424,236.3 approx for 1250 Qty
Status
Validity Over
Exit Price
₹337.3
Net P&L
0.8% Profit
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Mar 26 7:42 AM

Update
Trade Entered
Entry Price
₹340
TrackerBot @trackerbot
Mar 26 8:50 AM

Update
Validity Over
Exit Price
₹337.3
Net P&L
0.8% Profit
SUNPHARMA

Type
Buy
Instrument
SUNPHARMA
Entry Price
₹339.2
Price@Trade
₹339.2
Target Price
₹460
Stop Price
₹240
Valid Till
Mar 25, 2021 3:20 AM
Margin
₹339.2 approx for 1 Qty
Status
Exited
Exit Price
₹349.65
Net P&L
3.08% Profit
SUNP
Like
reply
Reply (1)
Latest replies

Update
Exited
Exit Price
₹349.65
Net P&L
3.08% Profit
@newsbot • Reputation: 2,570
CLSA upgrades these pharma stocks and raises target price
CLSA has tweaked its FY20-22 earnings estimates for the sector by 2 percent-3 percent.
Moneycontrol
Like
reply
Reply
@nehadhakadd • Reputation: -4,491
SUNPHARMA

Type
Sell
Instrument
SUNPHARMA
Entry Price
₹315.1
Price@Trade
₹315.1
Target Price
₹300
Stop Price
₹322
Valid Till
Mar 24, 2020 3:20 AM
Margin
₹315.1 approx for 1 Qty
Status
Stoploss Hit
Exit Price
₹322
Net P&L
-2.19% Loss
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Mar 23 8:45 AM

Update
Stoploss Hit
Exit Price
₹322
@JetageMatrixSystems • Reputation: 182,194
SUNPHARMA APR20 FUT

Type
Buy
Instrument
SUNPHARMA APR20 FUT
Entry Price
₹321.1  ₹328.5
Price@Trade
₹333.9
Target Price
₹420
Stop Price
₹224  ₹342.4
Valid Till
Apr 30, 2020 3:20 AM
Margin
₹115,707.7 approx for 1250 Qty
Status
Stoploss Hit
Exit Price
₹342.4
Net P&L
15.02% Profit
Like
reply
Reply (5)
Latest replies
J2K @JetageMatrixSystems
Mar 23 7:46 AM

Update
Entry Price Modified
Price @ Update
₹328.5
Original Entry Price
₹321.1
New Entry Price
₹328.5
TrackerBot @trackerbot
Mar 23 7:47 AM

Update
Trade Entered
Entry Price
₹328.5
J2K @JetageMatrixSystems
Mar 24 4:43 AM

Update
Stoploss Trailed
Price @ Update
₹342
Original SL
₹224
New SL
₹339.1
J2K @JetageMatrixSystems
Mar 24 7:52 AM

Update
Stoploss Trailed
Price @ Update
₹345.55
Original SL
₹339.1
New SL
₹342.4
TrackerBot @trackerbot
Mar 24 8:28 AM

Update
Stoploss Hit
Exit Price
₹342.4
@TTA • Reputation: 43,172

*SUNPHARMA RS 20.69 CRS NSE BLOCK TRADE; FOR~ 621263 SHARES, AT RS 333*
Like
reply
Reply
@albert • Reputation: 3
SUNPHARMA MAR20 FUT

Type
Buy
Instrument
SUNPHARMA MAR20 FUT
Entry Price
₹350  ₹366
Price@Trade
₹348.05
Target Price
₹370
Stop Price
₹340
Valid Till
Mar 23, 2020 3:20 AM
Status
Expired before entry
Like
reply
Reply (2)
Latest replies
Albert Wesker @albert
Mar 23 2:55 AM

Update
Entry Price Modified
Price @ Update
₹351
Original Entry Price
₹350
New Entry Price
366.0
TrackerBot @trackerbot
Mar 23 8:50 AM

Update
Expired before entry
Price @ Update
₹326.45
@OPTIONSONLY • Reputation: -54,063
SUNPHARMA APR20 FUT

Type
Sell
Instrument
SUNPHARMA APR20 FUT
Entry Price
₹366
Price@Trade
₹366
Target Price
₹320
Stop Price
₹380
Valid Till
Apr 20, 2020 3:20 AM
Margin
₹108,652.32 approx for 1250 Qty
Status
Exited
Exit Price
₹342.15
Net P&L
27.44% Profit
Like
reply
Reply (1)
Latest replies

Update
Exited
Exit Price
₹342.15
Net P&L
27.44% Profit
@mrresearch • Reputation: -14,839
SUNPHARMA

Type
Buy
Instrument
SUNPHARMA
Entry Price
₹373.5
Price@Trade
₹372.35
Target Price
₹377
Stop Price
₹370
Valid Till
Mar 20, 2020 3:20 AM
Margin
₹373.5 approx for 1 Qty
Status
Stoploss Hit
Exit Price
₹370
Net P&L
-0.94% Loss
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Mar 20 4:39 AM

Update
Trade Entered
Entry Price
₹373.5
TrackerBot @trackerbot
Mar 20 5:13 AM

Update
Stoploss Hit
Exit Price
₹370
@mrresearch • Reputation: -14,839
SUNPHARMA

Type
Buy
Instrument
SUNPHARMA
Entry Price
₹379.6
Price@Trade
₹375.2
Target Price
₹383
Stop Price
₹377
Valid Till
Mar 20, 2020 3:20 AM
Status
Exited before entry
Like
reply
Reply (1)
Latest replies
Mr Research @mrresearch
Mar 20 4:06 AM

Update
Exited before entry
Price @ Update
₹371.35
@newsbot • Reputation: 2,570
Coronavirus pandemic | Pharma companies ask sales representatives to work from home
India's largest drug maker Sun Pharma which has field force 9,500 plus covering over 400,000 doctors in every nook and corner of the country said it is encouraging employees in the field globally to work from home.
Moneycontrol
Like
reply
Reply
SUNPHARMA APR20 FUT

Type
Buy
Instrument
SUNPHARMA APR20 FUT
Entry Price
₹366.35
Price@Trade
₹366.35
Target Price
₹600
Stop Price
₹320
Valid Till
Apr 30, 2020 3:20 AM
Margin
₹110,914.18 approx for 1250 Qty
Status
Stoploss Hit
Exit Price
₹320
Net P&L
-52.24% Loss
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Mar 23 8:33 AM

Update
Stoploss Hit
Exit Price
₹320
@ExpertMahi • Reputation: 1,372

SELL SUNPHARMA BELOW 381 ONLY
SL 386
TAR 378 - 375
Like
reply
Reply (2)
Latest replies
EXPERT MAHI @ExpertMahi
Mar 18 3:39 AM

SUNPHARMA METLS 376🏄‍♀🏄‍♀
TARG 1 DONE.
START BOOKING... MORNING BREAKFAST DONE🥰
EXPERT MAHI @ExpertMahi
Mar 18 3:40 AM

SUNPHARMA - 666911


*Sun Pharmaceutical announces a buyback of Rs 1,700 crore*
17-Mar-2020,
The board of directors of Sun Pharmaceutical Industries has approved share buyback amid broad market sell-off. The board in today’s meeting, approved equity share buyback of Rs 1,700 crore at a maximum pric...
Read more...
1
reply
Reply
Calls Analyst in SUNPHARMA
For today only 👉Buy at / above: 375.39   Targe...

SUNPHARMA - 665764
Buy target achieved successfully
Like
reply
Reply
@newsbot • Reputation: 2,570
Sun Pharma board approves Rs 1,700cr share buy-back offer
In a regulatory filing the company said that the board of directors of the company, at its meeting held on Tuesday has approved the buy-back of its equity shares from the open market at a maximum price of Rs 425 per share for an aggregate maximum amount of up to Rs 1,700 crore.
Moneycontrol
Like
reply
Reply
  • SUNPHARMA - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization114,986.45
    Enterprise Value120,496.68
    Price to EarningsNA
    Price to Book Value5.03
    Return on Capital Employed-0.01
    Return on Equity-0.03
    Face Value1
    Dividend YieldNA
  • SUNPHARMA Share Price - Technicals

    keyboard_arrow_down
    SUNPHARMA - 52 Week High₹479.9
    SUNPHARMA - 52 Week Low₹312
  • SUNPHARMA - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    10-Feb-20Karvy Stock BrokingHold458
    7-Feb-20Prabhudas LilladherReduce412
    5-Feb-20Prabhudas LilladherReduce396
    9-Jan-20Prabhudas LilladherReduce396
    21-Dec-19Prabhudas LilladherReduce396
    SUNPHARMA Brokerage Price Target
  • SUNPHARMA Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Apr 3343.95389.8340375.95
    Apr 1353355.25338.4343.55
    Mar 31340.1355328.25352.3
    Mar 30321.65344312332.7
    Mar 27347352.5333338.25
  • SUNPHARMA Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹361.98
    30 Day Moving Average₹373.8
    50 Day Moving Average₹397.56
    100 Day Moving Average₹417.28
    200 Day Moving Average₹414.36
  • SUNPHARMA - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue7,9247,702.40.03
    Operating Profit-82795.27-9.68
    Profit Before Tax-520-32.4415.03
    Net Income-495-34.9513.16
  • SUNPHARMA - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds22,84419,7700.16
    Total Liabilities14,87114,1540.05
    Total Assets37,71433,9240.11
  • SUNPHARMA - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity-1,184-1,623.95-0.27
    Cash from Investing Activity1,4062,383.85-0.41
    Cash from Financing Activity-272-752.98-0.64
    Net Cash Flow-506.92-8.23
  • SUNPHARMA - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets-0.01NA
    Return on Equity-0.03NA
    Return on Capital Employed-0.010.01
  • SUNPHARMA - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.01
    3 Year CAGR Growth in Operating Profit-0.48
    3 Year CAGR Growth in EBIDTA1.86
    3 Year CAGR Growth in Net Income0.66
    3 Yr CAGR Growth - Diluted EPS0.71
  • SUNPHARMA - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue2.26
    5 Year CAGR Growth in Operating Profit-2.61
    5 Year CAGR Growth in EBIDTA-0.6
    5 Year CAGR Growth in Net Income-1.96
    3 Yr CAGR Growth - Diluted EPS-1.41
  • SUNPHARMA - Recent News

    keyboard_arrow_down
    NewsBot
    Mar 30 5:13 AM
    Sun Pharma share falls 7% on USFDA red flag, but pares all losses
    Moneycontrol
    NewsBot
    Mar 30 1:08 AM
    Stocks in the news: Stocks in the news: SBI, IDBI Bank, Tata Power, Graphite, Lupin, Godawari Power, Sun Pharma
    Moneycontrol
    NewsBot
    Mar 28 12:18 PM
    Coronavirus pandemic | Sun Pharma commits Rs 25 cr worth of drugs, sanitisers to fight COVID-19
    Moneycontrol
    NewsBot
    Mar 24 7:43 AM
    CLSA upgrades these pharma stocks and raises target price
    Moneycontrol
    NewsBot
    Mar 19 10:18 AM
    Coronavirus pandemic | Pharma companies ask sales representatives to work from home
    Moneycontrol
    NewsBot
    Mar 17 8:28 AM
    Sun Pharma board approves Rs 1,700cr share buy-back offer
    Moneycontrol
    NewsBot
    Mar 17 7:48 AM
    Sun Pharma share price gains 7% on buyback approval
    Moneycontrol
    NewsBot
    Mar 13 5:08 AM
    Sun Pharma share price rises 10% as board to consider share buyback
    Moneycontrol
    NewsBot
    Mar 13 1:18 AM
    Stocks in the news: Yes Bank, Sun Pharma, Escorts, BPCL, Indian Hotels, Tata Steel
    Moneycontrol
    NewsBot
    Mar 12 3:53 AM
    Sun Pharma board to consider share buyback plan next week
    Moneycontrol
  • SUNPHARMA - Related Communities

    keyboard_arrow_down
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Dr. Reddy's Laboratories Ltd. Sector...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Piramal Enterprises Ltd. Sector: Phar...
    Divi's Laboratories Ltd. Sector: Pha...
    Glenmark Pharmaceuticals Ltd. Sector...
    Strides Pharma Science Ltd. Sector: P...
    Apollo Hospitals Enterprise Ltd. Sec...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.